To assess the relationship between Sun2 expression and the prognosis of prostate cancer patient, Kaplan-Meier survival analysis was performed and the results showed that low Sun2 expression predicted poor survival of prostate cancer patients (P < 0.01) (Figure 2). This evidence concerns the gene SUN2 and prostate carcinoma.